FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083100228> ?p ?o ?g. }

• W2083100228 endingPage "444" @default.
• W2083100228 startingPage "437" @default.
• W2083100228 abstract "Oncolytic viral (OV) therapy has been considered as a promising treatment modality for brain tumors. Vasculostatin, the fragment of brain-specific angiogenesis inhibitor-1, shows anti-angiogenic activity against malignant gliomas. Previously, a vasculostatin-expressing oncolytic herpes simplex virus-1, Rapid Antiangiogenesis Mediated By Oncolytic virus (RAMBO), was reported to have a potent antitumor effect. Here, we investigated the therapeutic efficacy of RAMBO and cilengitide, an integrin inhibitor, combination therapy for malignant glioma. In vitro, tube formation was significantly decreased in RAMBO and cilengitide combination treatment compared with RAMBO or cilengitide monotherapy. Moreover, combination treatment induced a synergistic suppressive effect on endothelial cell migration compared with the control virus. RAMBO, combined with cilengitide, induced synergistic cytotoxicity on glioma cells. In the caspase-8 and -9 assays, the relative absorption of U87ΔEGFR cell clusters treated with cilengitide and with RAMBO was significantly higher than that of those treated with control. In addition, the activity of caspase 3/7 was significantly increased with combination therapy. In vivo, there was a significant increase in the survival of mice treated with combination therapy compared with RAMBO or cilengitide monotherapy. These results indicate that cilengitide enhanced vasculostatin-expressing OV therapy for malignant glioma and provide a rationale for designing future clinical trials combining these two agents." @default.
• W2083100228 created "2016-06-24" @default.
• W2083100228 creator A5004595871 @default.
• W2083100228 creator A5020419482 @default.
• W2083100228 creator A5022170837 @default.
• W2083100228 creator A5032713958 @default.
• W2083100228 creator A5033917464 @default.
• W2083100228 creator A5041131555 @default.
• W2083100228 creator A5059538840 @default.
• W2083100228 creator A5065128406 @default.
• W2083100228 creator A5070355923 @default.
• W2083100228 date "2013-07-05" @default.
• W2083100228 modified "2023-10-15" @default.
• W2083100228 title "The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus" @default.
• W2083100228 cites W1576773659 @default.
• W2083100228 cites W1600721209 @default.
• W2083100228 cites W1938388466 @default.
• W2083100228 cites W1968180412 @default.
• W2083100228 cites W1976520103 @default.
• W2083100228 cites W1976584637 @default.
• W2083100228 cites W2001753204 @default.
• W2083100228 cites W2005436740 @default.
• W2083100228 cites W2012442768 @default.
• W2083100228 cites W2014758132 @default.
• W2083100228 cites W2029773366 @default.
• W2083100228 cites W2031714805 @default.
• W2083100228 cites W2036258190 @default.
• W2083100228 cites W2039317622 @default.
• W2083100228 cites W2044923102 @default.
• W2083100228 cites W2055475004 @default.
• W2083100228 cites W2064735316 @default.
• W2083100228 cites W2065360869 @default.
• W2083100228 cites W2068124694 @default.
• W2083100228 cites W2080208032 @default.
• W2083100228 cites W2100668772 @default.
• W2083100228 cites W2104605014 @default.
• W2083100228 cites W2106253728 @default.
• W2083100228 cites W2108337464 @default.
• W2083100228 cites W2115516828 @default.
• W2083100228 cites W2123789088 @default.
• W2083100228 cites W2127554335 @default.
• W2083100228 cites W2139676810 @default.
• W2083100228 cites W2159723167 @default.
• W2083100228 cites W2171206916 @default.
• W2083100228 cites W2322364588 @default.
• W2083100228 doi "https://doi.org/10.1038/cgt.2013.38" @default.
• W2083100228 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4862362" @default.
• W2083100228 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23827879" @default.
• W2083100228 hasPublicationYear "2013" @default.
• W2083100228 type Work @default.
• W2083100228 sameAs 2083100228 @default.
• W2083100228 citedByCount "21" @default.
• W2083100228 countsByYear W20831002282014 @default.
• W2083100228 countsByYear W20831002282015 @default.
• W2083100228 countsByYear W20831002282016 @default.
• W2083100228 countsByYear W20831002282017 @default.
• W2083100228 countsByYear W20831002282019 @default.
• W2083100228 countsByYear W20831002282020 @default.
• W2083100228 countsByYear W20831002282021 @default.
• W2083100228 countsByYear W20831002282022 @default.
• W2083100228 countsByYear W20831002282023 @default.
• W2083100228 crossrefType "journal-article" @default.
• W2083100228 hasAuthorship W2083100228A5004595871 @default.
• W2083100228 hasAuthorship W2083100228A5020419482 @default.
• W2083100228 hasAuthorship W2083100228A5022170837 @default.
• W2083100228 hasAuthorship W2083100228A5032713958 @default.
• W2083100228 hasAuthorship W2083100228A5033917464 @default.
• W2083100228 hasAuthorship W2083100228A5041131555 @default.
• W2083100228 hasAuthorship W2083100228A5059538840 @default.
• W2083100228 hasAuthorship W2083100228A5065128406 @default.
• W2083100228 hasAuthorship W2083100228A5070355923 @default.
• W2083100228 hasBestOaLocation W20831002281 @default.
• W2083100228 hasConcept C150903083 @default.
• W2083100228 hasConcept C207001950 @default.
• W2083100228 hasConcept C2776999253 @default.
• W2083100228 hasConcept C2778227246 @default.
• W2083100228 hasConcept C2780394083 @default.
• W2083100228 hasConcept C3020616263 @default.
• W2083100228 hasConcept C502942594 @default.
• W2083100228 hasConcept C71924100 @default.
• W2083100228 hasConcept C82210918 @default.
• W2083100228 hasConcept C86803240 @default.
• W2083100228 hasConcept C98274493 @default.
• W2083100228 hasConceptScore W2083100228C150903083 @default.
• W2083100228 hasConceptScore W2083100228C207001950 @default.
• W2083100228 hasConceptScore W2083100228C2776999253 @default.
• W2083100228 hasConceptScore W2083100228C2778227246 @default.
• W2083100228 hasConceptScore W2083100228C2780394083 @default.
• W2083100228 hasConceptScore W2083100228C3020616263 @default.
• W2083100228 hasConceptScore W2083100228C502942594 @default.
• W2083100228 hasConceptScore W2083100228C71924100 @default.
• W2083100228 hasConceptScore W2083100228C82210918 @default.
• W2083100228 hasConceptScore W2083100228C86803240 @default.
• W2083100228 hasConceptScore W2083100228C98274493 @default.
• W2083100228 hasIssue "8" @default.
• W2083100228 hasLocation W20831002281 @default.
• W2083100228 hasLocation W20831002282 @default.
• W2083100228 hasLocation W20831002283 @default.

• next